News Release

University Of California-San Francisco (UCSF) Translational Symposium, September 10, To Focus On HIV Breakthrough And Immune Function

Meeting Announcement

University of California - San Francisco

UCSF will sponsor its 4th Annual Translational Research Symposium for HIV investigators on Thursday, September 10.

Titled "Antiretroviral Therapy: Preventing HIV Breakthrough & Rebuilding Immune Function," the one-day event will include a series of lectures reviewing the basic, clinical, and behavioral studies on the causes and consequences of virologic failure and the rebuilding of immune function.

The symposium is co-sponsored by the UCSF Center for AIDS Research and the AIDS Clinical Research Center, both programs of the UCSF AIDS Research Institute, and the Gladstone Institute of Virology and Immunology.

The program will take place in Cole Hall, UCSF Medical Sciences Building, 513 Parnassus Ave., San Francisco. MEDIA ARE INVITED TO COVER.

The program is as follows:

8:30-8:35 am
WELCOME -- Paul A. Volberding, MD, UCSF professor of medicine; director, UCSF Center for AIDS Research; director, UCSF AIDS Program and Medical Oncology at San Francisco General Hospital; and Warner C. Greene, MD, PhD, UCSF professor of medicine, microbiology and immunology; director, UCSF Center for AIDS Research; and director, Gladstone Institute of Virology and Immunology.

8:35-9:15 am
KEYNOTE ADDRESS: "Immunity to HIV--Does it Matter?" -- Bruce D. Walker, MD, director, AIDS Research Center, Massachusetts General Hospital and Harvard Medical School.


CAUSES AND CONSEQUENCES OF VIROLOGIC FAILURE

9:15-9:45 am
"LATENT RESERVOIRS FOR HIV-1: IMPLICATIONS FOR VIRUS ERADICATION" -- Robert Siliciano, MD, PhD, associate professor of medicine, John Hopkins University.

9:45-10:15 am
"HIV THERAPY: DYNAMICS, RESISTANCE AND RESERVOIRS" -- Doug Richman, MD, professor of pathology & medicine; co-director, Center for AIDS Research and AIDS Research Institute, UC San Diego.

10:15-10:45 am
DISCUSSION/BREAK

10:45-11:15 am
"TARGETING CELLULAR FACTORS: AN ALTERNATIVE TO CONTROL HIV REBOUND AND REBUILD IMMUNE FUNCTION"-- Franco Lori, MD, scientific director, Research Institute for Genetic Human Therapy, Georgetown University and Policlinico, San Matteo.

11:15-11:45 am
"BEHAVIOR AND BREAKTHROUGH" -- Frederick M. Hecht, MD, UCSF assistant professor of medicine.

Noon-1:00 pm
LUNCH BREAKOUT SESSIONS

  • Is Eradication Possible?
  • Immune Preservation After Virologic Failure
  • Extending Therapy to Developing Countries

REBUILDING IMMUNE FUNCTION

1:15-1:35 pm
"PREVALENCE OF ANTIVIRAL MEDICATION USE IN A PROBABILITY SAMPLE OF HIV SEROPOSITIVE MSMS IN MAJOR U.S. CITIES" -- Ronald D. Stall, PhD, MPH, UCSF associate professor of medicine.

1:35-1:55 pm
"PREVALENCE OF VIRAL DRUG RESISTANCE" -- Robert M. Grant, MD, MPH, MS, associate director, UCSF Center for AIDS Research; staff research scientist, Gladstone Institute of Virology and Immunology.

1:55-2:15 pm
"PREDICTING AND PREVENTING THE EMERGENCE OF ANTIRETROVIRAL DRUG RESISTANCE IN SAN FRANCISCO" -- Sally Blower, PhD, UCSF associate professor of microbiology, immunology and medicine.

2:15-2:45 pm
DISCUSSION/BREAK

2:45-3:15 pm
"VIRAL AND CELLULAR DYNAMICS IN HIV INFECTED LYMPHOID TISSUE" -- R. Pat Bucy, MD, PhD, associate professor of pathology, University of Alabama at Birmingham.

3:15-3:45 pm
"MONITORING OF THYMIC DEPENDENT T-CELL REGENERATION" -- Crystal Mackall, MD, investigator, Pediatric Oncology Branch, National Cancer Institute.

3:45-4:15 pm
"T-CELL PRODUCTION IN HIV-1 DISEASE" -- Joseph M. McCune, MD, PhD, associate investigator, Gladstone Institute of Virology and Immunology; UCSF associate professor of medicine.

4:15-4:30 pm
WRAP-UP -- Paul A. Volberding, MD, and Warner C. Greene, MD, PhD.

Media interested in covering the symposium, please call Corinna Kaarlela in the UCSF Mews Office at San Francisco General Hospital (415) 476-3804.

###



Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.